Softgel Capsules Market Size, Share, Growth, and Industry Analysis, By Type (Gelatin Type,Non-animal Type), By Application (Cannabis Extracts & CBD Industry,Health Supplements,Pharmaceutical,Others), Regional Insights and Forecast to 2035

Softgel Capsules Market Overview

The global Softgel Capsules Market size is projected to grow from USD 12955.59 million in 2026 to USD 13982.97 million in 2027, reaching USD 25747.13 million by 2035, expanding at a CAGR of 7.93% during the forecast period.

Globally, the Softgel Capsules Market is anchored by rising demand for nutraceuticals, dietary supplements, and pharmaceutical formulations. In 2024, the softgel capsules market was estimated at USD 9.3 billion (per GMI Insights) and by 2025 the value is projected to reach about USD 9.8 billion.

Focusing on the USA market, in 2022 the U.S. softgel capsules market was valued at USD 2.14 billion and the U.S. accounted for approximately 26.7 % share of global softgel capsule revenue.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 38 % of softgel demand comes from nutraceutical firms expanding global health supplement lines
• Major Market Restraint: 16 % of global raw gelatin supply is vulnerable to BSE regulations and supply chain constraints
• Emerging Trends: 24 % of new product launches in 2024 were vegetarian (non-animal) softgels
• Regional Leadership: North America held about 33.35 % of softgel share in 2024
• Competitive Landscape: Top 5 manufacturers account for over 45 % of global softgel output
• Market Segmentation: Gelatin-based softgels held ~75 % share vs non-animal ~25 % globally
• Recent Development: 22 % of new softgel capacities added in 2023–2024 were in Asia Pacific

Softgel Capsules Market Latest Trends

In recent years, the Softgel Capsules Market Trends have centered around vegetarian / non-animal softgels, enhanced bioavailability technologies, contract manufacturing growth, and geographic relocation of production. For instance, non-animal softgel formulations (HPMC, pullulan, alginate) held about USD 1.3 billion globally in 2024 (Precision Business Insights), reflecting increasing consumer demand for plant-based alternatives. Meanwhile, about 24 % of new softgel product launches in 2024 used vegetarian shells. Manufacturers are also incorporating self-emulsifying systems or liquid lipid matrices in ~29 % of new softgel fills to improve dissolution and absorption in low-solubility APIs.

Softgel Capsules Market Dynamics

The Softgel Capsules Market Dynamics reflect intertwined demand, supply, innovation, and regulatory forces: the global market was about USD 9.3 billion in 2024 and roughly USD 9.8 billion in 2025, with gelatin-based shells representing about 75% of volume and non-animal shells at approximately USD 1.3 billion in 2024, while nutraceuticals accounted for roughly 38% of demand, underscoring where volume and value pressure originate.

DRIVER

"Rising demand for nutraceuticals and health supplements"

Nutrition and preventive health trends are fueling the softgel capsules space. Around 38 % share of softgel demand comes from nutraceutical / health supplement firms globally. In the U.S., over 50 % of adults consume at least one dietary supplement daily, many in softgel form, contributing to the U.S. value of USD 2.14 billion in 2022. The aging global population – in 2024, persons aged 65+ accounted for ~10 % of global population – further supports softgel demand because softgels are easier to swallow.

RESTRAINT

"Dependency on gelatin raw material and regulatory control"

A major barrier is the reliance on animal-derived gelatin, which is subject to BSE / TSE regulations, halal/kosher certification demands, and supply volatility. Approximately 16 % of global gelatin supply is vulnerable to regulatory scrutiny, limiting some manufacturers.

OPPORTUNITY

"Development of non-animal / vegetarian softgels and specialty APIs"

There is strong opportunity in non-animal softgels, which held USD 1.3 billion in 2024. About 24 % of 2024 softgel launches adopted vegetarian shells. Further growth lies in specialty encapsulation techniques: 38 % of new variants used self-emulsifying platforms or lipid matrices.

CHALLENGE

"High regulatory hurdles, capsule stability, and manufacturing scale"

Softgel manufacturing is capital intensive and technically demanding. Moisture control is critical—~5 % of batches fail on moisture stability tests globally. Regulatory certification (FDA, EMA, PMDA) adds typical delays of 6–9 months, and ~14 % of new plant proposals require additional remediation for GMP compliance.

Softgel Capsules Market Segmentation

The Softgel Capsules Market Segmentation divides by Type (Gelatin / Animal-based vs Non-animal / Vegetarian) and by Application (Cannabis & CBD, Health Supplements, Pharmaceutical, Others). Gelatin type historically holds ~75 % share of the market versus non-animal at ~25 %. On the application side, Health Supplements (nutraceuticals) dominate with ~38 % share, pharmaceuticals may account for ~22 %, cannabis/CBD ~7 %, and others (cosmetic, veterinary, animal health) ~13 %.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Gelatin / Animal-based: Gelatin / animal-based softgel capsules remain the backbone of the industry, occupying roughly 75 % share of global softgel volume. In 2024, of the global softgel volume, ~3 out of 4 units used gelatin shells (Precedence Research). The gelatin type benefits from decades of validated manufacturing knowledge, regulatory precedence, and supplier networks.

The Gelatin Softgel Capsules market size is valued at USD 9,102.8 million in 2025, projected to reach USD 17,867.6 million by 2034, holding 75.8% share with a CAGR of 7.85%, supported by wide pharmaceutical and nutraceutical adoption across global markets.

Top 5 Major Dominant Countries in the Gelatin Type Segment

• United States: The Gelatin Softgel Capsules market size in the United States is valued at USD 2,735.8 million in 2025, accounting for 22.8% share with a CAGR of 7.89%, supported by more than 1,200 supplement brands and 400+ pharmaceutical approvals that use gelatin-based softgels in prescription drugs and OTC medicines.
• China: The Gelatin Softgel Capsules market size in China stands at USD 1,864.6 million in 2025, holding 15.5% share with a CAGR of 7.95%, fueled by the presence of over 7,000 nutraceutical firms and government-backed gelatin sourcing strategies for softgel production in health and wellness applications nationwide.
• Germany: The Gelatin Softgel Capsules market size in Germany is estimated at USD 1,092.5 million in 2025, representing 9.1% share with a CAGR of 7.72%, driven by strict EU pharmaceutical regulations, a strong drug innovation pipeline, and advanced supplement consumption among a population of more than 80 million citizens.
• India: The Gelatin Softgel Capsules market size in India is projected at USD 986.3 million in 2025, accounting for 8.2% share with a CAGR of 7.93%, supported by rapidly growing generic pharmaceutical exports, increasing supplement consumption, and significant expansion of domestic capsule manufacturing capacity across major pharma hubs.
• Japan: The Gelatin Softgel Capsules market size in Japan is valued at USD 812.6 million in 2025, contributing 6.8% share with a CAGR of 7.70%, reflecting strong OTC vitamin consumption, established pharmaceutical formulations, and advanced dietary supplement research supported by an aging population and innovative R&D sectors.

Non-animal / Vegetarian: The Non-animal or vegetarian softgel (HPMC, pullulan, alginate) segment currently addresses ~25 % of global softgel demand by volume, with estimates of USD 1.3 billion in 2024 (Precision Business Insights). This segment is growing faster, driven by vegan consumer demand, halal/kosher markets, and regulatory restrictions on animal products. In 2024, about 24 % of new product launches used vegetarian shells.

The Non-Animal Softgel Capsules market size is valued at USD 2,900.9 million in 2025, projected to reach USD 5,987.8 million by 2034, holding 24.2% share with a CAGR of 8.15%, driven by rising vegetarian, vegan, and clean-label demand.

Top 5 Major Dominant Countries in the Non-Animal Type Segment

• United States: The Non-Animal Softgel Capsules market size in the United States is valued at USD 870.2 million in 2025, accounting for 29.9% share with a CAGR of 8.10%, driven by consumer adoption of vegetarian supplements and over 24% of new product launches utilizing non-animal shells.
• China: The Non-Animal Softgel Capsules market size in China is projected at USD 678.4 million in 2025, representing 23.4% share with a CAGR of 8.23%, supported by more than 300 capsule manufacturing units and rising demand for plant-based nutraceutical and pharmaceutical formulations across the domestic market.
• United Kingdom: The Non-Animal Softgel Capsules market size in the United Kingdom stands at USD 410.7 million in 2025, holding 14.2% share with a CAGR of 8.05%, supported by strict regulatory alignment, strong consumer preference for plant-based solutions, and rising demand for certified clean-label supplements.
• India: The Non-Animal Softgel Capsules market size in India is valued at USD 384.2 million in 2025, contributing 13.2% share with a CAGR of 8.18%, fueled by rapid nutraceutical startup growth, vegetarian consumer preference, and expanding manufacturing investments focused on non-animal formulations.
• Japan: The Non-Animal Softgel Capsules market size in Japan is estimated at USD 310.8 million in 2025, holding 10.7% share with a CAGR of 7.96%, reflecting strong adoption of clean-label OTC vitamins, pharmaceutical-grade HPMC shells, and high demand for pullulan-based vegetarian capsules.

BY APPLICATION

Cannabis Extracts & CBD Industry: The Cannabis / CBD softgel application segment is emerging, projected to account for ~7 % of total health supplement softgels by 2025. Although small historically, cannabis-derived softgel usage is scaling in North America, Europe, and parts of Latin America. In 2023, CBD softgel SKUs grew by ~23 % year-on-year.

The Cannabis Extracts & CBD Softgel Capsules market size is valued at USD 780.2 million in 2025, projected to reach USD 1,632.5 million by 2034, holding 6.5% share with a CAGR of 8.25%, driven by legalization trends and CBD nutraceutical innovation.

Top 5 Major Dominant Countries in the Cannabis Extracts & CBD Application

• United States: Market size USD 268.4 million in 2025, 34.4% share, CAGR 8.30%, supported by rapid CBD legalization, 1,000+ CBD nutraceutical brands, and widespread adoption of CBD oil-based softgel supplements in retail and e-commerce channels.
• Canada: Market size USD 142.7 million in 2025, 18.3% share, CAGR 8.18%, fueled by federal legalization of cannabis products, strong nutraceutical brand presence, and significant consumer demand for CBD-based supplements and wellness capsules.
• China: Market size USD 110.5 million in 2025, 14.2% share, CAGR 8.28%, driven by industrial hemp cultivation, growing nutraceutical firms, and demand for cannabis-based exports to legalized foreign markets.
• Germany: Market size USD 94.6 million in 2025, 12.1% share, CAGR 8.12%, supported by legalization of medical cannabis products, increasing pharmaceutical-grade CBD usage, and strong demand for OTC cannabis-infused supplements.
• United Kingdom: Market size USD 81.2 million in 2025, 10.4% share, CAGR 8.05%, reflecting consumer adoption of CBD nutraceuticals, legalization of certain cannabis oils, and investments from European supplement companies into CBD softgel formats.

Health Supplements: The Health Supplements or nutraceutical application dominates, representing ~38 % of softgel demand by value and volume. In 2024, more than 1,200 softgel SKUs launched globally in vitamins, omega-3, botanicals, vitamin D, and multivitamins. In the U.S., over 35 % of adults have vitamin D deficiency, prompting demand for vitamin D softgel supplements. Omega-3 / fish oil softgels account for ~20 % of supplement softgel volume.

The Health Supplements Softgel Capsules market size is valued at USD 4,560.9 million in 2025, projected to reach USD 9,192.7 million by 2034, holding 38.0% share with a CAGR of 7.97%, driven by vitamin, mineral, omega-3, and herbal supplement demand.

Top 5 Major Dominant Countries in the Health Supplements Application

• United States: Market size USD 1,592.1 million in 2025, 34.9% share, CAGR 8.02%, supported by high supplement usage, more than 1,200 brands, and widespread adoption of omega-3 and multivitamin softgels.
• China: Market size USD 975.8 million in 2025, 21.4% share, CAGR 7.95%, fueled by rising disposable incomes, supplement penetration, and consumer preference for gelatin and vegetarian softgels in health products.
• India: Market size USD 621.3 million in 2025, 13.6% share, CAGR 8.12%, driven by nutraceutical startups, vegetarian supplement demand, and rapid supplement consumption across urban areas.
• Germany: Market size USD 541.5 million in 2025, 11.9% share, CAGR 7.90%, reflecting advanced supplement adoption, strict EU nutrition labeling, and demand for premium omega-3 and vitamin D softgels.
• Japan: Market size USD 402.8 million in 2025, 8.8% share, CAGR 7.75%, supported by elderly supplement consumption, advanced health research institutions, and growing use of vegetarian shells for clean-label supplements.

Pharmaceutical: The Pharmaceutical application of softgels covers prescription drugs, over-the-counter (OTC) medicines, and clinical trial formulations. In 2024, pharmaceutical softgels accounted for ~22 % of market value. Around 160 anti-inflammatory, cardiovascular, and CNS APIs are available as softgel formulations. In 2023–2024, over 25 pharmaceutical companies filed IND / NDA applications containing softgel dosage forms.

The Pharmaceutical Softgel Capsules market size is valued at USD 3,042.9 million in 2025, projected to reach USD 6,153.8 million by 2034, holding 25.3% share with a CAGR of 8.02%, supported by prescription drugs, OTC medicines, and advanced formulations.

Top 5 Major Dominant Countries in the Pharmaceutical Application

• United States: Market size USD 975.6 million in 2025, 32.0% share, CAGR 8.05%, driven by 400+ softgel pharmaceutical approvals, extensive use in NSAIDs, cardiovascular, and CNS drugs, and mature healthcare infrastructure.
• China: Market size USD 698.2 million in 2025, 23.0% share, CAGR 8.08%, supported by expanding domestic pharmaceutical sector, rising drug exports, and government-backed R&D in capsule formulations.
• Germany: Market size USD 416.7 million in 2025, 13.7% share, CAGR 7.95%, driven by pharmaceutical innovation pipelines, EU regulations, and adoption of gelatin-based softgels in prescription and OTC medicines.
• India: Market size USD 366.4 million in 2025, 12.0% share, CAGR 8.10%, reflecting generic pharmaceutical exports, growing domestic drug formulations, and preference for softgels in bioavailability enhancement.
• Japan: Market size USD 278.5 million in 2025, 9.2% share, CAGR 7.84%, reflecting high demand for OTC drugs, advanced pharmaceutical research institutions, and adoption of softgels in clinical trial dosage forms.

Others: The “Others” application includes veterinary, cosmetic / personal care, animal health, probiotic formulations, and specialty diagnostics. In 2024, others accounted for ~13 % of softgel market value. Veterinary softgels are used in ~120 farm animal supplement lines globally. Cosmetic / beauty supplement softgels (collagen, skin micronutrients) grew ~15 % in 2023–2024.

The Others Softgel Capsules market size is valued at USD 719.0 million in 2025, projected to reach USD 1,336.4 million by 2034, holding 6.0% share with a CAGR of 7.76%, covering veterinary, cosmetics, probiotics, and specialty uses.

Top 5 Major Dominant Countries in the Others Application

• United States: Market size USD 226.0 million in 2025, 31.4% share, CAGR 7.80%, supported by veterinary medicine, probiotic softgel innovation, and cosmetic supplements.
• China: Market size USD 154.8 million in 2025, 21.5% share, CAGR 7.84%, reflecting pet supplements, probiotic formulations, and cosmetic applications.
• Germany: Market size USD 107.3 million in 2025, 14.9% share, CAGR 7.70%, supported by strict veterinary medicine regulations and probiotic use.
• India: Market size USD 96.2 million in 2025, 13.4% share, CAGR 7.85%, driven by veterinary health supplements and cosmetic nutraceuticals.
• Japan: Market size USD 85.6 million in 2025, 11.9% share, CAGR 7.68%, reflecting cosmetic collagen softgels and probiotic supplement adoption.

Regional Outlook for the Softgel Capsules Market

Regionally, North America leads with ~33 % share of softgel demand as of 2024, driven by nutraceutical and pharmaceutical consumption. Europe secures ~27 % share with strong supplement and health regulatory infrastructure. Asia-Pacific is rapidly scaling, contributing ~23 % of new production additions in 2023. Middle East & Africa (MEA) currently hold ~7 – 8 % share but forecasted to grow with rising supplement penetration. These four regions dominate the Softgel Capsules Market Outlook, with the greatest momentum in Asia and MEA owing to expanding middle classes, regulatory reforms, and CDMO investment.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America remains the largest softgel market region, capturing ~33.35 % of global share in 2024 (Precedence Research). In 2024, North America softgel consumption was ~USD 3.10 billion (33.35 % of USD 9.3 billion) and in 2025 consumption is projected to exceed USD 3.25 billion. The United States leads domestically: with USD 2.14 billion market size in 2022 (Fortune Business Insights) and capturing ~26.7 % of global revenue in that period.

The North America Softgel Capsules market size is valued at USD 3,994.3 million in 2025, projected to reach USD 7,812.1 million by 2034, accounting for 33.3% global share with a CAGR of 7.92%, supported by expanding nutraceutical consumption, pharmaceutical innovations, and widespread OTC supplement demand across the region.

North America – Major Dominant Countries in the Softgel Capsules Market

• United States: The Softgel Capsules market size in the United States is valued at USD 3,025.6 million in 2025, representing 24.9% share with a CAGR of 7.95%, driven by more than 1,200 active supplement brands, over 400 pharmaceutical approvals, and the fact that more than 50% of adults regularly consume dietary supplements in softgel formats.
• Canada: The Softgel Capsules market size in Canada is projected at USD 502.4 million in 2025, holding 4.1% share with a CAGR of 7.88%, supported by the growth of its healthcare sector, rising nutraceutical adoption rates, and strict regulatory support promoting clean-label supplement formulations for both domestic and export markets.
• Mexico: The Softgel Capsules market size in Mexico is estimated at USD 285.6 million in 2025, contributing 2.3% share with a CAGR of 7.86%, reflecting increased supplement consumption, growth in domestic generic drug manufacturing, and expanding consumer health awareness across middle-class populations in urban regions.
• Cuba: The Softgel Capsules market size in Cuba is valued at USD 109.3 million in 2025, holding 0.9% share with a CAGR of 7.70%, supported by government-led healthcare initiatives, the introduction of OTC supplement adoption programs, and a steadily growing but early-stage nutraceutical manufacturing industry.
• Puerto Rico: The Softgel Capsules market size in Puerto Rico is projected at USD 71.4 million in 2025, representing 0.6% share with a CAGR of 7.65%, driven by the presence of large pharmaceutical manufacturing hubs, export-driven supplement production activities, and growing investments in capsule R&D facilities.

EUROPE

Europe holds approximately 27 % share of global softgel consumption in 2024 (estimating from Precedence / Europe share). In 2024, European consumption was roughly USD 2.51 billion (on 9.3 billion base). The region’s leadership lies in countries such as Germany, UK, France, Italy, and Spain. Germany alone contributes ~18 % of European softgel usage, driven by robust pharmaceutical and nutraceutical sectors and supplement regulatory frameworks in the EU. UK and France each account for ~12 %–14 % of region share, backed by strong demand for beauty and health supplements.

The Europe Softgel Capsules market size is valued at USD 3,240.9 million in 2025, projected to reach USD 6,341.7 million by 2034, accounting for 27.0% global share with a CAGR of 7.85%, supported by strict EU regulatory standards, growing demand for vegetarian softgels, and rising consumer preference for premium health and wellness supplements across major economies.

Europe – Major Dominant Countries in the Softgel Capsules Market

• Germany: The Softgel Capsules market size in Germany is valued at USD 864.3 million in 2025, holding 7.2% share with a CAGR of 7.82%, driven by pharmaceutical innovation pipelines, nutraceutical expansion, and advanced supplement consumption among a population exceeding 80 million citizens.
• United Kingdom: The Softgel Capsules market size in the United Kingdom is projected at USD 701.5 million in 2025, representing 5.8% share with a CAGR of 7.87%, fueled by rising vegetarian capsule adoption, advanced healthcare infrastructure, and consumer preference for clean-label dietary supplements.
• France: The Softgel Capsules market size in France stands at USD 632.6 million in 2025, contributing 5.3% share with a CAGR of 7.79%, supported by strong nutraceutical demand, OTC drug penetration, and growing health awareness programs.
• Italy: The Softgel Capsules market size in Italy is valued at USD 543.2 million in 2025, accounting for 4.5% share with a CAGR of 7.75%, driven by rising adoption of probiotics, collagen supplements, and vitamin-based formulations in softgel formats.
• Spain: The Softgel Capsules market size in Spain is estimated at USD 499.3 million in 2025, holding 4.1% share with a CAGR of 7.72%, reflecting increasing supplement usage, omega-3 fish oil softgel demand, and strong consumer health awareness.

ASIA-PACIFIC

Asia-Pacific is an accelerating force in the softgel landscape. In 2023–2024, Asia accounted for about 21 % of new softgel capacity additions, particularly in China, India, South Korea, and Southeast Asia. In 2025, Asia-Pacific softgel consumption is projected to reach ~USD 2.25 billion (assuming ~23 % share). China and India dominate: China adds ~45 % of new capacity in 2024, while India’s domestic softgel market volume grew ~17 % year-on-year. Japan and South Korea are mature markets, with Japan contributing ~9 % to regional share.

The Asia Softgel Capsules market size is valued at USD 2,760.9 million in 2025, projected to reach USD 6,139.8 million by 2034, representing 23.0% global share with a CAGR of 8.25%, driven by rapid industrialization, pharmaceutical growth, and expanding middle-class supplement consumption across fast-growing economies.

Asia – Major Dominant Countries in the Softgel Capsules Market

• China: The Softgel Capsules market size in China is valued at USD 1,490.8 million in 2025, representing 12.4% share with a CAGR of 8.30%, supported by more than 7,000 nutraceutical firms, government-backed R&D, and expanding manufacturing capabilities.
• India: The Softgel Capsules market size in India is projected at USD 1,014.2 million in 2025, accounting for 8.4% share with a CAGR of 8.28%, driven by vegetarian capsule demand, generic pharmaceutical exports, and nutraceutical startup growth.
• Japan: The Softgel Capsules market size in Japan is estimated at USD 812.5 million in 2025, holding 6.8% share with a CAGR of 7.96%, reflecting OTC drug expansion, dietary supplement consumption, and advanced R&D in capsule technologies.
• South Korea: The Softgel Capsules market size in South Korea is valued at USD 545.3 million in 2025, contributing 4.5% share with a CAGR of 8.05%, supported by biotech advancements, consumer health awareness, and nutraceutical product development.
• Australia: The Softgel Capsules market size in Australia is projected at USD 421.3 million in 2025, representing 3.5% share with a CAGR of 7.90%, reflecting strong fish oil exports, regulatory compliance, and increasing supplement penetration.

MIDDLE EAST & AFRICA

Middle East & Africa (MEA) currently contributes ~7 – 8 % of global softgel demand, translating to ~USD 0.70–0.80 billion consumption in 2024. In 2025, MEA is projected to cross USD 0.85 billion softgel usage. The Gulf Cooperation Council (GCC) nations—especially UAE, Saudi Arabia, and Qatar—contribute ~55 % of MEA’s softgel demand, driven by high per capita supplement use and medical tourism. UAE, with its free zone manufacturing hubs, hosts ~12 regional softgel supplement brands producing outward into Africa.

The Middle East & Africa Softgel Capsules market size is valued at USD 1,007.6 million in 2025, projected to reach USD 1,984.5 million by 2034, accounting for 8.4% global share with a CAGR of 7.78%, supported by healthcare infrastructure development, growing nutraceutical penetration, and expanding pharmaceutical investments across emerging economies.

Middle East & Africa – Major Dominant Countries in the Softgel Capsules Market

• Saudi Arabia: The Softgel Capsules market size in Saudi Arabia is valued at USD 278.6 million in 2025, holding 2.3% share with a CAGR of 7.82%, driven by rapid supplement adoption, high healthcare spending, and government-backed nutraceutical programs.
• United Arab Emirates: The Softgel Capsules market size in the UAE is projected at USD 196.3 million in 2025, representing 1.6% share with a CAGR of 7.79%, supported by pharmaceutical free-zone hubs, supplement manufacturing, and export opportunities.
• South Africa: The Softgel Capsules market size in South Africa is estimated at USD 178.4 million in 2025, contributing 1.5% share with a CAGR of 7.74%, reflecting nutraceutical market expansion, growing supplement adoption, and healthcare investments.
• Egypt: The Softgel Capsules market size in Egypt is valued at USD 177.5 million in 2025, holding 1.5% share with a CAGR of 7.70%, driven by expanding supplement penetration, pharmaceutical manufacturing growth, and consumer health awareness campaigns.
• Nigeria: The Softgel Capsules market size in Nigeria is projected at USD 146.8 million in 2025, representing 1.2% share with a CAGR of 7.65%, supported by rapid urbanization, healthcare reforms, and increasing supplement demand across urban populations.

List of Top Softgel Capsules Companies

• Catalent, Inc.
• Capsugel
• Strides Pharma Science Limited
• EuroCaps Ltd.
• International Vitamin Corporation
• Captek Softgel International Inc.
• Sirio Pharma Co. Ltd.
• Soft Gel Technologies, Inc.
• Weihai Baihe Biology Technological Co. Ltd.
• Amway
• Patheon

Catalent, Inc.: Catalent produces over 80 billion doses annually, controls 15%+ global softgel share, operates in 50+ sites worldwide, and partners with 1,000+ pharmaceutical and nutraceutical clients.

Capsugel (Lonza Group): Capsugel manufactures more than 200 billion capsules yearly, holds around 13% global market share, serves 100+ countries, and operates with 4,000+ employees specializing in gelatin and vegetarian softgel technologies.

Investment Analysis and Opportunities

The investment landscape in the Softgel Capsules Market is robust as manufacturers and CDMOs expand capacity, integrate new technologies, and enter emerging geographies. In 2023–2024, globally more than USD 320 million in capital was deployed toward new softgel encapsulation lines, clean-room expansions, and R&D labs. Asia-Pacific attracted ~28 % of that capital, with China hosting over 40 new or upgraded softgel units. Europe received ~22 % of investment, focused on vegetarian shell technology and process automation upgrades. North America saw ~18 % of investment, primarily in modernizing older capsule facilities to meet virtual audits and serialization standards.

New Product Development

Innovation in the Softgel Capsules Market is largely focused on vegetarian shell formulations, enhanced delivery systems, dual-chamber designs, custom fill systems, and smart packaging / traceability. Of all new softgel SKUs in 2024, ~24 % used vegetarian shells (Precision Business Insights), marking a pivot away from classic gelatin. In addition, ~29 % of new formulations adopted self-emulsifying lipid matrices or advanced solubilization within the fill to enhance bioavailability of poorly soluble APIs. Manufacturers also launched ~12 % of SKUs as dual-chamber or delayed-release softgels, facilitating sequential release of actives.

Five Recent Developments

• In 2024, ~22 % of added softgel capacity globally was located in Asia-Pacific, especially China and India.
• In 2023–2024, ~24 % of new softgel product launches used vegetarian (non-animal) shells.
• In 2023, ~17 % of new CDMO installations supported continuous encapsulation lines.
• In 2024, ~12 % of new softgel SKUs across pharma and nutraceutical categories were dual-chamber or delayed release designs.
• In 2024, approximately 8 % of softgel blister packs introduced embedded QR / RFID traceability for serialization and anti-counterfeit compliance.

Report Coverage of Softgel Capsules Market

The Softgel Capsules Market Research Report provides comprehensive coverage of market dynamics, segmentation, regional performance, competitive positioning, investment trends, and forecast outlook. The report includes global market size metrics, e.g. USD 9.3 billion in 2024 and USD 9.8 billion in 2025 (GMI Insights), and breaks down type segmentation into gelatin (75 % share) vs non-animal (~25 % share). Each application segment—Cannabis/CBD, Health Supplements (~38 % share), Pharmaceutical (~22 %), and Others (~13 %)—is elaborated with SKU trends, fill technology usage, and regulatory aspects. Regional analysis spans North America (33 % share in 2024), Europe (~27 %), Asia-Pacific (rapid capacity growth), and MEA (~7–8 %), with country-level depth on U.S., China, India, Germany, UAE, South Africa, etc.

Softgel Capsules Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 12955.59 Million in 2026
Market Size Value By	USD 25747.13 Million by 2035
Growth Rate	CAGR of 7.93% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Gelatin Type Non-animal Type By Application : Cannabis Extracts & CBD Industry Health Supplements Pharmaceutical Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample